Unknown PHASE4 INTERVENTIONAL 1-arm NCT02011724

A Study Of Pain And Quality Of Life Outcomes In Subjects With a Single Painful Venous Leg Ulcer Treated With Apligraf®

An Open Label, Multi Center, Post Marketing Study Of Pain And Quality Of Life Outcomes In Subjects With a Single Painful Venous Leg Ulcer Treated With Apligraf®

Sponsor: Organogenesis

Conditions Venous Leg Ulcers

Interventions Apligraf

Updated 5 times since 2017 Last updated: Dec 10, 2013 Started: Nov 30, 2013 Primary completion: Jan 31, 2014 Completion: Jan 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02011724, this PHASE4 trial focuses on Venous Leg Ulcers and remains ongoing. Sponsored by Organogenesis, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Feb 2017 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE4

First recorded

Nov 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Organogenesis

Data source: Organogenesis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mineola, United States